About Monod
Monod is a Healthcare company based in Seattle (United States) founded in 2021 by Alfredo Quijano Rubio and Daniel Silva Manzano. Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules. Monod has raised $25 million across 2 funding rounds from investors including HHS, Matrix Capital and Pack Ventures. Its chief executive, as recorded, is Daniel Silva Manzano. Monod offers products and services including NovoBody, LuxSitâ„¢ Pro, and NovoLISA. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Biosensors. Its legal entity is Monod Bio Inc. Its competitors include Cardea Bio, Hememics Biotechnologies and Nix; 3 of its 3 listed competitors have raised funding.
Company details
Monod was founded in 2021 and is based in Seattle, United States. Biosensors are created by the company within the biotechnology sector to identify viral proteins, toxins, antibodies, and various other molecules. The platform relies on engineered proteins combined with de novo computational protein design. Detection capabilities extend to a broad spectrum of target molecules, supporting applications in health and diagnostics.
- Total Equity Funding$25M (USD)
in 2 rounds
- Latest Funding Round$290.07K (USD), Grant
Jan 2024
- InvestorsHHS
& 7 more
Products & Services of Monod
Monod offers a comprehensive portfolio of products and services, including NovoBody, LuxSit™ Pro, and NovoLISA.
AI-powered platform for computational protein engineering in research.
Advanced system for clinical diagnostics using protein design techniques.
Software for life sciences applications in protein analysis and innovation.
Funding Insights of Monod
Monod has successfully raised a total of $25M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $290.07 thousand completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 2
- Last Round Grant — $290,066
- First Round $25M
(Aug 2022)
- Investors Count 8
All 2 funding rounds of Monod with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $290,066 | Grant | – | – | |
| Aug 2022 | $25M | Seed | – | Matrix |
8 investors in total: 8 institutional.
Investors in Monod
Monod has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Matrix Capital and Pack Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pack Ventures is involved in unspecified business activities. | packvc.com | |||
Investments in multiple sectors are made by Sahsen Ventures. | sahsen.com | Seattle, United States | ||
Early investments in science-focused startups are made by BOOM Capital. | boomcap.co | |||
Early-stage venture capital is provided to US companies across sectors. | wrfseattle.org | Seattle, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Global health technologies are supported through strategic investments. | ghicfunds.org | |||
Provides investment advisory services to ultra-high-net-worth individuals and families. | 2021 | cercanolp.com | Bellevue, United States | |
Investment advisory and wealth management services are provided. | 2000 | matrixcapital.com | Chicago, United States |
Investor details for Monod
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Monod
13 people are tracked at Monod (5 in leadership, 1 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Alfredo Quijano Rubio | Co-Founder | Leadership |
Daniel Silva Manzano | Co-Founder & CEO | Leadership |
Lori Tonnes JD MBA | Senior Director, IP & Legal | Leadership |
Daniel-Adriano S. | CEO and President | Leadership |
William Lee | Sr. Director Of Finance And Operations | Leadership |
Timothy Still | Chairman | Board & advisors |
Vanessa Peng | Research Operations Specialist | Team |
Marcin Ura | Principal Scientist | Team |
Jonathan Wagner | Scientist | Team |
Élyse Fischer | Postdoctoral Scientist | Team |
Tania Berrocal | Científico Asociado | Team |
Deniz Ulge | Operations and Administrative | Team |
Gary Geiss | Product Development & Strategy Manager | Team |
Complete people profiles for Monod
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Monod
3 dated milestones of Monod across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Monod is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Grant, of $290K.
Competitors of Monod
Monod has 3 listed competitors in our database, 3 of them funded. They include Cardea Bio, Hememics Biotechnologies and Nix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardeabio.com | 2019 | San Diego, United States | $21.8M | Digital graphene biosensors are developed using machine learning. | ||
| hememics.com | 2009 | Gaithersburg, United States | $4.6M | 13 | Biopreservation platform for mammalian cells and biologics is developed. | |
| nixbiosensors.com | 2015 | Boston, United States | $6.95M | Sweat-based biosensors are provided for body hydration monitoring. |
Detailed competitors of Monod
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Monod
The website of Monod (monod.bio) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 27.4% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Monod (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Monod
Complete news archive for Monod
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monod
Monod was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Monod is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Daniel Silva Manzano is the CEO of Monod, as recorded in our data. They have also founded this company.
Monod is a funded company, having raised a total of $25M across 2 funding rounds to date. The company's 1st funding round was a Seed of $25M, raised on Aug 2022.
Monod was founded in 2021 and is based in Seattle, United States. Biosensors are created by the company within the biotechnology sector to identify viral proteins, toxins, antibodies, and various other molecules. The platform relies on engineered proteins combined with de novo computational protein design. Detection capabilities extend to a broad spectrum of target molecules, supporting applications in health and diagnostics.
Monod's top competitors include Nix, Cardea Bio and Hememics Biotechnologies.
Monod offers NovoBody, LuxSitâ„¢ Pro, and NovoLISA.
Monod has 8 investors. Key investors include HHS, Matrix Capital, Pack Ventures, Sahsen Ventures, and BOOM Capital.
Monod operates through Monod Bio Inc..